UTI AMC announces MD and CEO transition effective February 1, 2026

CEO resignedKey managerial personnel resignedManagement Changes View source PDF Explain this filing

UTIAMC · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.4%Reaction day

₹1350.00

prior close

₹1351.90

announcement price

After-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)-0.7%+0.2% vs market

Asset Management Company peers, median of 5sector-0.4%-0.0% vs sector

On the reaction day the stock moved 0.2 pts more than Nifty Smallcap 250 and in line with its Asset Management Company peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.9

10m

-0.7

15m

-0.4

30m

-0.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.4-0.7+0.2-0.4-0.0

Next day

-2.2-0.4-1.8-1.0-1.2

-1.2-0.3-0.9+2.2-3.3

-0.7+0.0-0.7+0.6-1.3

-0.8+0.7-1.5+0.1-0.9

+0.1+0.7-0.5+0.0+0.1

-0.1+1.6-1.8+0.5-0.6

15d

+1.2+0.4+0.8-4.3+5.5

-2.5+0.3-2.8-1.8-0.6

-9.6+2.0-11.6-5.9-3.8

-15.9-2.3-13.6-8.4-7.5

UpDownMarket · Nifty Smallcap 250Sector · Asset Management Company peers, median of 5Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

UTI AMC said MD and CEO Imtaiyazur Rahman will leave his executive role after market close on January 31, 2026, ahead of his scheduled June 2026 term end, under a succession plan. He will advise the new CEO from February 1 to June 12, 2026. Current Chief Investment Officer Vetri Subramaniam was appointed additional executive director and MD and CEO for February 1, 2026 to January 31, 2031, subject to shareholder approval.

Likely market impact

The planned handover supports continuity, but the appointment needs shareholder approval and investors will assess the new CEO's strategy.